Corticosteroid‐Induced Osteonecrosis in COVID ‐19: A Call For Caution

Osteoporosis Management in the Era of COVID ‐19

(2020) Elaine W Yu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Caution against corticosteroid-based COVID-19 treatment

(2020) Chong Tang et al.   LANCET

High-dose but Not Low-dose Corticosteroids Potentially Delay Viral Shedding of Patients With COVID-19

(2020) Sijia Li et al.   CLINICAL INFECTIOUS DISEASES

Corticosteroids in diabetes patients infected with COVID-19

(2020) Fuxue Deng et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up

(2018) Weiguo Wang et al.   INTERNATIONAL ORTHOPAEDICS

Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis

(2016) R. Zhao et al.   OSTEOPOROSIS INTERNATIONAL

The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome

(2014) K. J. Guo et al.   Bone & Joint Journal

Osteonecrosis of the femoral head in SARS patients: seven years later

(2012) Feng-Chao Zhao et al.   European Journal of Orthopaedic Surgery and Traumatology